Trial intelligence / Profile preview

Combination vs Monotherapy in Elderly Advanced Gastric Cancer

NCT02114359Phase 3Completed

Sponsor
Seoul National University Hospital
Start
Feb 2014
Primary completion
Feb 2020
Modality
Nanoparticles, DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 3 trial of Cisplatin micelle injection (HA132), oxaliplatin in gastric adenocarcinoma, sponsored by Seoul National University Hospital. Started Feb 2014; status: completed.

02

Drugs

Cisplatin micelle injection (HA132)oxaliplatin
03

Conditions

gastric adenocarcinoma

Beyond the preview

Go deeper on NCT02114359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02114359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call